Serious adverse events in healthy volunteers identified during clinical trials

被引：0
|
作者：
Coimbra Hurtado, Jimena [1 ]
机构：
[1] CIM St Pau, Barcelona, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2018年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CP50
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Serious adverse events in clinical trials with TAVR and SAVR
    Barth, U.
    [J]. HERZ, 2019, 44 (06) : 526 - 533
  • [2] Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
    Fonck, Simon
    Deserno, Thomas
    [J]. MEDINFO 2017: PRECISION HEALTHCARE THROUGH INFORMATICS, 2017, 245 : 1262 - 1262
  • [3] A call for improved reporting on serious adverse events in clinical trials
    Schutte, Aletta E.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 (11) : 2154 - 2155
  • [4] Complications of hypothermia: Interpreting 'serious,' 'adverse,' and 'events' in clinical trials
    de Toledo, Joan Sanchez
    Bell, Michael J.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2010, 11 (03) : 439 - 441
  • [5] Clinical trials facing "Serious Adverse Events" during the ongoing COVID-19 pandemic
    Parikh, Purvish M.
    Mehta, Prashant
    Krishna Kumar MVT
    Govind Babu, K.
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (03) : 295 - 298
  • [6] Serious adverse events occurring during clinical trials: a French university hospital promotor experience
    Llau, M. E.
    Roques, N.
    Cantagrel, A.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 70 - 70
  • [7] Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events
    McManus, Lisa
    Davis, Arlene
    Forcier, Rebecca L.
    Fisher, Jill A.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2019, 47 (02): : 323 - 333
  • [8] Quality of serious adverse events reported to an academic sponsor of clinical trials
    Crepin, S.
    Villeneuve, C.
    Favier, R.
    Merle, L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 65 - 65
  • [9] Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
    Molinari, Nicolas
    Suehs, Carey
    Vachier, Isabelle
    Pahus, Laurie
    Halimi, Laurence
    Gamez, Anne-Sophie
    Chanez, Pascal
    Bourdin, Arnaud
    [J]. CLINICAL TRIALS, 2019, 16 (04) : 440 - 442
  • [10] Quantitative and qualitative evaluations of data of serious adverse events reported to the vigilance unit during clinical trials
    Aydin, D.
    Blanc, E.
    Nguon, M.
    Robinson, P.
    Bodenan, E.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 83 - 83
12345